Comprehensive Literature Review: Recent Advances in Diagnosing and Managing Patients with Poorly Differentiated Thyroid Carcinoma

Table 1

Prevalence of genetic alterations in patients with various thyroid carcinomas.

Altered gene	PDTC	PTC	FTC	ATC
RET/PTC	0%	20%	0%	0%
TP53	20–30%	0%	0%	65–70%
BRAF	15%	45%	0%	20–25%
RAS	30–35%	10–15%	45%	50–55%
β-catenin	20–25%	0%	0%	65%
PAX8 : PPARγ	0%	0%	35%	0%

PDTC: poorly differentiated thyroid carcinoma.
PTC: papillary thyroid carcinoma.
FTC: follicular thyroid carcinoma.
ATC: anaplastic thyroid carcinoma.